Here, we examine hype in the context of a perennial tension at the heart of patenting communication: between advertising innovation and keeping it secret.
Alicia Ely Yamin combines academic research that bridges law, development, and public health with grassroots work and policy advocacy.
In short, 109’s creators’ stated intent to make psilocybin therapy accessible to help the growing mental health care crisis has resulted in a policy that doesn’t allow for any of it.
The Satanic Temple argues that abortion is a protected religious right.
WHOOP announced their product is eligible for FSA and HSA spending. That might change the way we think about the tax code and health policy.
A whole-person response to OUD and other substance use disorders needs a well-coordinated whole-of-government response.
A brief sketch of the potential for Rights of Nature legislation to safeguard sacred plant medicines by recognizing them as rights holders unto themselves.
Psychedelic science appears to ignore many of the lessons learned from decades of research in other fields.
As a historian of psychoactive pharmaceuticals in the 20th century U.S., I see history rhyming in potentially dangerous ways in the current psychedelic boom.
Without committing to open science practices, we risk producing a psychedelics industry with the same efficacy and integrity as the self-help industry.
